Key result
Prevalence-dependent thresholding at 0.9% vs 5% LMCAD prevalence increased negative predictive value (99.5% vs 98.2%) but lowered sensitivity (64.5% vs 85.3% at 1:100 cost ratio).
Why the study?
Does prevalence-dependent thresholding in a clinical and exercise ECG model improve both sensitivity and negative predictive value for ruling out left main coronary artery disease in patients with suspected chronic coronary syndromes?
Does prevalence-dependent thresholding in a clinical and exercise ECG model improve both sensitivity and negative predictive value for ruling out left main coronary artery disease in patients with suspected chronic coronary syndromes?
Answers are grounded in this paper and cite their sources.
In prevalence-dependent diagnostic models for left main coronary artery disease, a higher negative predictive value in lower-prevalence settings can mask a substantial drop in sensitivity, resulting in over a third of diseased patients being missed.
This commentary refers to ‘Standard clinical and stress ECG variables to exclude left main and left main-equivalent disease: the MASTER study’, by M. De Carlo et al., https://doi.org/10.1093/eurheartj/ehag464 and the discussion piece ‘Prevalence-dependent thresholding and the safety of ruling out left main disease’, by M. De Carlo et al., https://doi.org/10.1093/eurheartj/ehag860. De Carlo et al. report a clinical and exercise electrocardiographic model intended to defer coronary angiography or coronary computed tomography angiography in patients with suspected chronic coronary syndromes. At an assumed 5% prevalence of left main coronary artery disease (LMCAD) and a 1:100 misclassification cost ratio, the negative predictive value was 98.2%.1 Their Discussion further states that a lower LMCAD prevalence would increase both sensitivity and negative predictive value, making adoption more advantageous. That interpretation is not supported by the supplementary analyses: after prevalence-dependent threshold selection, the higher negative predictive value at 0.9% prevalence was accompanied by lower sensitivity. At 5% prevalence, optimism-adjusted sensitivity and negative predictive value were 85.3% and 98.2% at the 1:100 ratio and 74.4% and 97.7% at 1:50.1 At 0.9% prevalence, Supplementary Table 7 reported sensitivities of 64.5% and 63.0%, with a negative predictive value of 99.5% under both ratios.1 The Mayo Clinic validation showed the same pattern: sensitivity fell from 87.2% to 79.5% at 1:100 and from 84.6% to 69.2% at 1:50, despite higher negative predictive values.1 These estimates imply that the proportion of affected patients missed increased from 14.7% to 35.5% at 1:100 and from 25.6% to 37.0% at 1:50. A lower prevalence reduces the absolute number of false negatives per 1000 patients, but it does not reduce the probability of missing LMCAD among patients who have the disease.
No takes yet. Share an insight, caveat, or question.
Jidong Peng (2026) conducted an editorial in Suspected chronic coronary syndromes with potential left main coronary artery disease (LMCAD). Prevalence-dependent thresholding in a clinical and exercise ECG model (MASTER study) vs. Different assumed LMCAD prevalences (0.9% vs 5%) and misclassification cost ratios (1:100 vs 1:50) was evaluated on Sensitivity and negative predictive value for excluding left main coronary artery disease (LMCAD). Prevalence-dependent thresholding at 0.9% vs 5% LMCAD prevalence increased negative predictive value (99.5% vs 98.2%) but lowered sensitivity (64.5% vs 85.3% at 1:100 cost ratio).
Synapse has enriched 10 related papers. Consider them for comparative context: